News & Articles

Watch this on-demand webinar to discover Abcam’s manufacturing workflow for producing bioactive proteins

Teams uses mathematical modelling study to guide preparations for future health strategies

A first of its kind study demonstrates voltage outside of biological cells, with potential implications for cardiovascular disease, cancer and fertility treatment

Find out about the management of digital transformation and outdated analysis software to prevent loss of digital data and stay GxP compliant

Including a new section for embedded organoid assays, and new data on mitochondrial membrane potential assays and phagocytosis assays

Join leading researchers online to explore the latest advances and common challenges in the field of breath biopsy

Awarded jointly to Benjamin List and David W.C. MacMillan "for the development of asymmetric organocatalysis"

New life sciences brand enables breakthroughs to market with a fully integrated portfolio which promises unparalleled sample exploration and management solutions

Abcam scientist, Dr. Jimmy Theriault, discusses how to determine if proteins are functionally active using cell-based and biochemical assays

This new oncology service supports unique in vitro investigations into the PK/PD relationship

Syukuro Manabe, Klaus Hasselmann and Giorgio Parisi honored for their groundbreaking contributions to our understanding of complex physical systems

The panels complete Bio-Rad’s set of Bio-Plex™ Pro Multiplex SARS-CoV-2 Human Serology Panels for detection of antibodies against four SARS-CoV-2 antigens

Gain insights on topics from antibody performance and cell line development to food safety method validation and more

Imperial College London has launched a pioneering new Institute to tackle some of the biggest challenges in infectious disease.

New module is designed to provide life science researchers with high-resolution images

Guest blog by PromoCell explores if HLA-type could be a key differentiator in disease outcomes, and in developing treatments

Advance your biopharma research through HPLC with this first-of-its-kind application-focused resource

ELRIG’s Impact Award, supported by SelectScience, is presented to an early career professional who has made a significant impact in the drug discovery community

The FDA cleared the first new major technological improvement for Computed Tomography (CT) imaging in nearly 10 years

The shared CLIA lab aims to help diagnostics start-ups, including Australian-based Minomic, more rapidly enter the U.S. market

Latest technologies aim to improve speed, sensitivity and flexibility for clinical testing and research related to COVID-19, cell and gene therapy, autoimmune disease and drugs of abuse

Customers will benefit from enhanced development and manufacturing capabilities, including high-density microarray printing

Measurement of anti-S1/RBD antibodies, neutralizing antibodies targeting S1/RBD, and specific T-cells using EUROIMMUN tests supports evaluation of the immune reaction to SARS-CoV-2 following vaccination or infection